Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000127

Options or other derivatives

  • SVP, Chief Financial Officer acquired 163,666 shares (grant or award)
  • SVP, Chief Financial Officer returned 163,666 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Branning Todd P. SVP, Chief Financial Officer 2019-11-13 Returned to the company · Stock Option −163,666 0 D: show line 1 in the form
Branning Todd P. SVP, Chief Financial Officer 2019-11-13 Grant or award · Stock Option +163,666 163,666 D: show line 2 in the form
Loading xslF345X03/wf-form4_157377035410885.xml…